Design, synthesis, biological evaluation and computational investigation of Thiadiazole Benzimidazole derivatives bearing a Chlorophyrimidine pharmacophore as potent CLK2 inhibitors and anticancer agents.
Cdc2-like kinase 2 (CLK2) has emerged as an attractive anticancer therapeutic target because of its crucial role in pre-mRNA splicing and tumor growth. Here, we designed and synthesized a novel series of thiadiazole-based benzimidazole derivatives 15a-l incorporating chloropyrimidine pharmacophore and evaluated for CLK...